Bahar Uncu Ulu

5PUBLICATIONS
109CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)HaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 13, 2025
Anti-T lymphocyte globulin plus posttransplant cyclophosphamide 25 mg/kg versus posttransplant cyclophosphamide 50 mg/kg in patients with acute leukemias.

Abdullah Karakus, Tayfur Toptas, Mehmet Sinan Dal

|Sep 13, 2021
Brentuximab vedotin and bendamustine: an effective salvage therapy for relapsed or refractory Hodgkin lymphoma patients.

Bahar Uncu Ulu, Mehmet Sinan Dal, İpek Yönal Hindilerden

|Mar 23, 2021
Recovery of Symmetrical Peripheral Gangrene of Limbs in a Patient After Performing Hemoadsorption in Septic Shock.

Bahar Uncu Ulu, Tuğçe Nur Yiğenoğlu, Tuba Hacıbekiroğlu

|Nov 25, 2020
Gemcitabine, dexamethasone and cisplatin (GDP) is an effective and well-tolerated mobilization regimen for relapsed and refractory lymphoma: a single center experience

Hikmettullah Batgi, Semih Başcı, Mehmet Sinan Dal

|Jul 23, 2019
A Multi-Center Study on the Efficacy of Eltrombopag in Management of Refractory Chronic Immune Thrombocytopenia: A Real-Life Experience

Demet Çekdemir, Serkan Güvenç, Füsun Özdemirkıran

Pageof 1

Frequent Collaborators

4 joint publications

Mehmet Sinan Dal

4 joint publications

Tuğçe Nur Yiğenoğlu

3 joint publications

Fevzi Altuntaş

2 joint publications

Turgay Ulaş